| Authors: |
Einstein DJ; Division of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA.; Harvard Medical School, Boston, MA., Halbert B; Division of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA., Denize T; Harvard Medical School, Boston, MA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Department of Pathology, Massachusetts General Hospital, Boston, MA., Matar S; Harvard Medical School, Boston, MA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA., West DJ; Department of Pathology, Brigham and Women's Hospital, Boston, MA., Gupta M; Harvard Medical School, Boston, MA.; Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA., Andrianopoulos E; Division of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA., Seery V; Division of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA., Herman C; Iovance Biotherapeutics, San Carlos, CA., Onimus K; Iovance Biotherapeutics, San Carlos, CA., Wells A; Iovance Biotherapeutics, San Carlos, CA., Bunch B; Iovance Biotherapeutics, San Carlos, CA., Signoretti S; Harvard Medical School, Boston, MA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA., Natarajan A; Iovance Biotherapeutics, San Carlos, CA., Veerapathran A; Iovance Biotherapeutics, San Carlos, CA., McDermott DF; Division of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA.; Harvard Medical School, Boston, MA. |
